$49.17
+0.80 (+1.65%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+41.13%
1Y
+84.09%
YTD
+73.99%
Open$49.05
Previous Close$48.37
Day High$49.90
Day Low$48.67
52W High$55.67
52W Low$25.17
Volume—
Avg Volume2.02M
Market Cap8.30B
P/E Ratio125.54
EPS$0.38
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$31.02
Above
SMA 200
$29.87
Above
RSI (14)
32.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
23 analysts
Price Target
+157.1% upside
Current
$49.17
$49.17
Target
$126.40
$126.40
$90.34
$126.40 avg
$146.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.48B | 1.34B | 1.89B |
| Net Income | 241.77M | 197.99M | 267.01M |
| Profit Margin | 16.4% | 15.6% | 14.1% |
| EBITDA | 259.68M | 224.47M | 438.15M |
| Free Cash Flow | — | — | 233.31M |
| Rev Growth | +9.9% | +9.9% | +6.3% |
| Debt/Equity | — | — | 0.25 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |